Perspective Therapeutics (CATX) Gains from Investment Securities (2016 - 2025)
Perspective Therapeutics (CATX) has disclosed Gains from Investment Securities for 14 consecutive years, with $231000.0 as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities rose 30.51% to $231000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5000.0 through Dec 2025, down 103.4% year-over-year, with the annual reading at $732577.0 for FY2025, 90.04% down from the prior year.
- Gains from Investment Securities hit $231000.0 in Q4 2025 for Perspective Therapeutics, up from -$14000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $10.3 million in Q2 2023 to a low of -$653000.0 in Q2 2022.
- Historically, Gains from Investment Securities has averaged $1.5 million across 5 years, with a median of $125000.0 in 2021.
- Biggest YoY gain for Gains from Investment Securities was 110413.8% in 2023; the steepest drop was 383.33% in 2023.
- Year by year, Gains from Investment Securities stood at $7.3 million in 2021, then crashed by 97.94% to $150000.0 in 2022, then tumbled by 383.33% to -$425000.0 in 2023, then surged by 141.65% to $177000.0 in 2024, then surged by 30.51% to $231000.0 in 2025.
- Business Quant data shows Gains from Investment Securities for CATX at $231000.0 in Q4 2025, -$14000.0 in Q3 2025, and -$84000.0 in Q2 2025.